Edetic Acid

Edetic Acid

SCHEMBL6249529

O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O.OO.[MgH2]

nearest known ligand 0.93

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 2/20 0.93
▸ EYA2 O00167 1/20 0.93
▸ APP P05067 1/20 0.93
▸ ACE P12821 1/20 0.93
▸ BLM P54132 2/20 0.88
▸ PMP22 Q01453 2/20 0.88
▸ TSHR P16473 2/20 0.88
▸ KDM4E B2RXH2 2/20 0.88
▸ ALOX15 P16050 2/20 0.88
▸ LMNA P02545 1/20 0.88
▸ CHRM2 P08172 1/20 0.88
▸ ADRA2A P08913 1/20 0.88
▸ DRD1 P21728 1/20 0.88
▸ SLC6A2 P23975 1/20 0.88
▸ SLC6A4 P31645 1/20 0.88
▸ CYP2C19 P33261 1/20 0.88
▸ ADRA1A P35348 1/20 0.88
▸ DRD3 P35462 1/20 0.88
▸ SLC6A3 Q01959 1/20 0.88
▸ HRH3 Q9Y5N1 1/20 0.88

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Edetic Acid SCHEMBL1396907 1.00 TDP1 (0.93) TDP1EYA2APPACEBLM
Edetic Acid SCHEMBL9702663 1.00 TDP1 (0.93) TDP1EYA2APPACEBLM
Edetic Acid SCHEMBL1033235 0.97 TDP1 (0.88) TDP1EYA2APPACEBLM
Edetic Acid SCHEMBL4355076 0.97 TDP1 (0.88) TDP1EYA2APPACEBLM
Edetic Acid SCHEMBL28414011 0.97 TDP1 (0.88) TDP1EYA2APPACEBLM
Edetic Acid SCHEMBL7074848 0.97 TDP1 (0.88) TDP1EYA2APPACEBLM
Edetic Acid SCHEMBL8090019 0.97 TDP1 (0.88) TDP1EYA2APPACEBLM
Edetic Acid SCHEMBL8381723 0.97 TDP1 (0.88) TDP1EYA2APPACEBLM
Edetic Acid SCHEMBL10891778 0.97 TDP1 (0.88) TDP1EYA2APPACEBLM
Edetic Acid SCHEMBL28636599 0.97 TDP1 (0.88) TDP1EYA2APPACEBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1562454-A2 METHODS AND SYSTEMS FOR HAIR COLORING AND HIGHLIGHTING L'OREAL (FR) 2005-08-17 — — EP claimed
WO-2004041020-A2 METHODS AND SYSTEMS FOR HAIR COLORING AND HIGHLIGHTING L'OREAL (FR) 2004-05-21 — — WO claimed
US-20040089316-A1 Methods and systems for hair coloring and highlighting L'OREAL S.A. (FR) 2004-05-13 — — US claimed
CN-100405950-C Method and system for hair dyeing and lightening OREAL (FR) 2008-07-30 — — CN disclosed
CN-1711041-A Methods and systems for hair coloring and highlighting OREAL (FR) 2005-12-21 — — CN disclosed
EP-1562454-A2 METHODS AND SYSTEMS FOR HAIR COLORING AND HIGHLIGHTING L'OREAL (FR) 2005-08-17 — — EP disclosed
WO-2004041020-A2 METHODS AND SYSTEMS FOR HAIR COLORING AND HIGHLIGHTING L'OREAL (FR) 2004-05-21 — — WO disclosed
US-20040089316-A1 Methods and systems for hair coloring and highlighting L'OREAL S.A. (FR) 2004-05-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040089316-A1 Methods and systems for hair coloring and highlighting KIT, SUCLG1, PRDM7 TDP1 1518/4885EYA2 30/4885APP 3757/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback